The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial
Journal article
Watson M. et al, (2024), Therapeutic advances in musculoskeletal disease, 16
The protocol of a clinical effectiveness trial comparing standard step up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomised controlled trial
Journal article
Watson M. et al, (2024), Therapeutic advances in musculoskeletal disease
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Journal article
Abhishek A. et al, (2024), Lancet rheumatol, 6, e92 - e104
Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia.
Journal article
Barber VS. et al, (2023), Bmj open, 13
Optimising Psoriatic Arthritis Therapy with Immunological Methods to Increase Standard Evaluation: The protocol of an open-label multi-centre, parallel-group, two arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis.
Journal article
RICHARDS D., (2023), Bmj open
HOW SHOULD WE BEST MEASURE PARTICIPANT-REPORTED `AVERAGE HAND PAIN': COMPARISON OF TWO METHODS FROM A RANDOMIZED PLACEBO-CONTROLLED FEASIBILITY STUDY OF POST-MENOPAUSAL WOMEN WITH HAND OSTEOARTHRITIS
Conference paper
Williams JA. et al, (2023), Osteoarthritis and cartilage, 31, S187 - S188
Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: primary report from the HOPE-e randomised, placebo-controlled, feasibility study.
Journal article
Williams JAE. et al, (2022), Lancet rheumatol, 4, e725 - e737
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial.
Journal article
Abhishek A. et al, (2022), Lancet respir med, 10, 840 - 850
Two-week interruption in methotrexate treatment versus treatment continued as usual and COVID-19 booster immunity in adults with inflammatory conditions (VROOM study): a randomised open label, superiority trial
Journal article
Abhishek A. et al, (2022), The lancet respiratory medicine
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study).
Journal article
Abhishek A. et al, (2022), Bmj open, 12
HAND OSTEOARTHRITIS: INVESTIGATING PAIN EFFECTS IN A RANDOMISED PLACEBO-CONTROLLED FEASIBILITY STUDY OF ESTROGEN-CONTAINING THERAPY (HOPE-E): REPORT ON THE PRIMARY FEASIBILITY OUTCOMES
Conference paper
Williams JAE. et al, (2022), Annals of the rheumatic diseases, 81, 1616 - 1617
Is Treating Painful Hand Osteoarthritis with Hormone Replacement Therapy Feasible? Primary Results from a Randomised Controlled Trial in Post-menopausal Women
Conference paper
Williams J. et al, (2022), Arthritis & rheumatology, 74, 3763 - 3765
Hand Osteoarthritis: investigating Pain Effects of estrogen-containing therapy (HOPE-e): a protocol for a feasibility randomised placebo-controlled trial.
Journal article
Marian IR. et al, (2021), Pilot feasibility stud, 7
A Multicentre Observational Psoriatic Arthritis Cohort Study Addressing Real-life Outcomes of a Treat to Target Approach in Routine Clinical Practice.
Journal article
Coates L. et al, (2021)
Clinical effectiveness of symptomatic therapy compared with standard step-up care for the treatment of low-impact psoriatic oligoarthritis: the two-arm parallel group randomised POISE feasibility study.
Journal article
Rombach I. et al, (2021), Ther adv musculoskelet dis, 13
A successful strategy for recruiting participants not in a care pathway to a CTIMP on time and to target
Conference paper
FRANCIS E. et al, (2019)
Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial.
Journal article
Nanchahal J. et al, (2018), Ebiomedicine, 33, 282 - 288
SELECTIVE INTERNAL RADIOTHERAPY (SIRT) IN METASTATIC COLORECTAL CANCER PATIENTS WITH LIVER METASTASES: PRELIMINARY PRIMARY CARE RESOURCE USE AND UTILITY RESULTS FROM THE FOXFIRE RANDOMISED CONTROLLED TRIAL
Conference paper
Fusco R. et al, (2017), Value in health, 20, A445 - A446